InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the complete record of transactions filed by Upadhyay Suketu. Director active across 2 companies, notably Zimmer Biomet Holdings, INC.. Cumulatively, 18 filings have been logged. History available since 1 July 2021. The latest transaction was disclosed on 6 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Upadhyay Suketu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
10,217 shares0Common StockSEC:0001533149-26-000009:0
6,364 shares0Common StockSEC:0001533149-26-000007:0
5,445 shares0Common StockSEC:0001533149-26-000005:0
10,632 shares0Common StockSEC:0001533149-25-000007:0
796 shares0Common StockSEC:0000875320-25-000190:0
4,560 shares0Common StockSEC:0001062993-25-004969:0
5,446 shares0Common StockSEC:0001062993-25-003336:0
21,622 shares0Common StockSEC:0001062993-25-002913:0
15,948 shares0Common StockSEC:0001062993-24-018908:0
1,001 shares0Common StockSEC:0000875320-24-000133:0
4,561 shares0Common StockSEC:0001062993-24-006027:0
7,043 shares0Common StockSEC:0001062993-24-004690:0
3,768 shares0Common StockSEC:0001062993-23-014447:0
1,168 shares0Common StockSEC:0001209191-23-027060:0
3,860 shares0Common StockSEC:0001062993-23-004620:0
3,768 shares0Common StockSEC:0001062993-22-015943:0
1,558 shares0Common StockSEC:0000899243-22-018783:0
3,655 shares0Common StockSEC:0001062993-21-006235:0
18 of 18 declarations
About Upadhyay Suketu
Upadhyay Suketu has filed 18 disclosures in total. In the 18 recent filings we hold, the most common transaction nature is option exercise, with filings spanning 2021-07-02 to 2026-03-10. The companies mentioned are Zimmer Biomet Holdings, INC., where he is Exec VP, CFO, and Vertex Pharmaceuticals INC / MA, where he is Director.
